ES2469265B1 - METHODS OF SELECTION OF CUTANEOUS CELL LYMPHOMA THERAPY - Google Patents

METHODS OF SELECTION OF CUTANEOUS CELL LYMPHOMA THERAPY Download PDF

Info

Publication number
ES2469265B1
ES2469265B1 ES201231760A ES201231760A ES2469265B1 ES 2469265 B1 ES2469265 B1 ES 2469265B1 ES 201231760 A ES201231760 A ES 201231760A ES 201231760 A ES201231760 A ES 201231760A ES 2469265 B1 ES2469265 B1 ES 2469265B1
Authority
ES
Spain
Prior art keywords
selection
methods
cell lymphoma
lymphoma therapy
cutaneous cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES201231760A
Other languages
Spanish (es)
Other versions
ES2469265A1 (en
Inventor
Pinilla Miguel Angel Piris
Diez José Pedro Vaque
Magunacelaya Nerea Martinez
Romero Pablo Luis Ortiz
Gomez Margarita Sanchez-Beato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fundacion Instituto de Investigacion Marques de Valdecilla IDIVAL
Original Assignee
FUNDACION CIENTIFICA de la ASOCIACION ESPANOLA CONTRA EL CANCER
FUNDACION DE INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO PUERTA DE HIERRO DE MAJADAHONDA
Fundacion Instituto de Investigacion Marques de Valdecilla IDIVAL
Servicio Cantabro de Salud
Fundacion Investigacion Biomedica Hospital Universitario 12 Octubre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUNDACION CIENTIFICA de la ASOCIACION ESPANOLA CONTRA EL CANCER, FUNDACION DE INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO PUERTA DE HIERRO DE MAJADAHONDA, Fundacion Instituto de Investigacion Marques de Valdecilla IDIVAL, Servicio Cantabro de Salud, Fundacion Investigacion Biomedica Hospital Universitario 12 Octubre filed Critical FUNDACION CIENTIFICA de la ASOCIACION ESPANOLA CONTRA EL CANCER
Priority to ES201231760A priority Critical patent/ES2469265B1/en
Priority to PCT/ES2013/070795 priority patent/WO2014076344A1/en
Publication of ES2469265A1 publication Critical patent/ES2469265A1/en
Application granted granted Critical
Publication of ES2469265B1 publication Critical patent/ES2469265B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES201231760A 2012-11-14 2012-11-14 METHODS OF SELECTION OF CUTANEOUS CELL LYMPHOMA THERAPY Expired - Fee Related ES2469265B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES201231760A ES2469265B1 (en) 2012-11-14 2012-11-14 METHODS OF SELECTION OF CUTANEOUS CELL LYMPHOMA THERAPY
PCT/ES2013/070795 WO2014076344A1 (en) 2012-11-14 2013-11-13 Methods for selecting therapy for cutaneous t-cell lymphoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201231760A ES2469265B1 (en) 2012-11-14 2012-11-14 METHODS OF SELECTION OF CUTANEOUS CELL LYMPHOMA THERAPY

Publications (2)

Publication Number Publication Date
ES2469265A1 ES2469265A1 (en) 2014-06-17
ES2469265B1 true ES2469265B1 (en) 2015-03-06

Family

ID=50730632

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201231760A Expired - Fee Related ES2469265B1 (en) 2012-11-14 2012-11-14 METHODS OF SELECTION OF CUTANEOUS CELL LYMPHOMA THERAPY

Country Status (2)

Country Link
ES (1) ES2469265B1 (en)
WO (1) WO2014076344A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820711B2 (en) * 2006-11-14 2010-10-26 Pharmacyclics Inc. Uses of selective inhibitors of HDAC8 for treatment of T-cell proliferative disorders
US20100285516A1 (en) * 2007-04-13 2010-11-11 Pharmacyclics, Inc. Calcium flux as a pharmacoefficacy biomarker for inhibitors of histone deacetylase

Also Published As

Publication number Publication date
WO2014076344A1 (en) 2014-05-22
ES2469265A1 (en) 2014-06-17

Similar Documents

Publication Publication Date Title
DK2863990T3 (en) MEDICAL MICROELECTRODE
CO7020913A2 (en) Pde9 inhibitors with basic structure of imidazotriazinone
DK3281664T3 (en) NATIONAL SUBMISSION DEVICES
CO7061086A2 (en) Combinations of active compounds
CO7091186A2 (en) N-cyclolamides as nematicides
DK2917462T3 (en) WELL INSULATION
EP2968549A4 (en) Methods of cell culture
DK2900806T3 (en) Three-dimensional cell culture
DK2815483T3 (en) MULTIROOM DATAR CHARGER
BR112013010099A2 (en) boronates as arginase inhibitors
EP2971040A4 (en) Methods of cell culture
EP2971014A4 (en) Methods of cell culture
DK2912455T3 (en) POWER DEVICE
BR112013033974A2 (en) combination therapy
BR112014007029A2 (en) improved methods of gene therapy
CL2014002030A1 (en) Alpha-amylase
EP2856131A4 (en) Electrophoresis gel cassette
BR112014016917A8 (en) cell processing
GB2525562B (en) Methods for purification of biological cells
DK3211410T3 (en) Electrode and its use
DK3590960T3 (en) IGG-STIMULATED REMMYELINIZATION OF PERIPHERAL NERVES
FI20126218A (en) power device
ES2469265B1 (en) METHODS OF SELECTION OF CUTANEOUS CELL LYMPHOMA THERAPY
DK2720533T3 (en) Stimulation device
FR2997080B1 (en) INHIBITORS OF NEPRILYSINE

Legal Events

Date Code Title Description
PC2A Transfer of patent

Owner name: FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VA

Effective date: 20140430

FG2A Definitive protection

Ref document number: 2469265

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20150306

FD2A Announcement of lapse in spain

Effective date: 20211004